Home > > > > > Report Detail

Global Insulin API Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 14-Sep-2022
No. of pages: 117
Inquire Before Buying

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Insulin API market is projected to reach US$ 2137.4 million by 2028 from an estimated US$ 1800.5 million in 2022, at a CAGR of 2.9% during 2023 and 2028.

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Insulin API.

The Insulin API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Insulin API market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Novo Nordisk

- Sanofi-Aventis

- Eli Lilly

- Tonghua Dongbao

- Ganlee

- United Laboratory

- Biocon

- Amphastar

- Wockhardt

- Julphar Diabetes

- Torrent Pharma

Product Type Insights

Global markets are presented by Insulin API type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Insulin API are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Insulin API Segment by Type

- Regular Human Insulin

- Insulin Analogue

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Insulin API market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Insulin API market.

Insulin API Segment by Application

- Fast-Acting

- Premix

- Long-Acting

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Insulin API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Insulin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Insulin API industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin API

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Insulin API Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Insulin API Product Introduction
1.2 Market by Type
1.2.1 Global Insulin API Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market by Application
1.3.1 Global Insulin API Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Fast-Acting
1.3.3 Premix
1.3.4 Long-Acting
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin API Market Size Estimates and Forecasts
2.1.1 Global Insulin API Revenue 2017-2028
2.1.2 Global Insulin API Sales 2017-2028
2.2 Insulin API Market Size by Region: 2022 Versus 2028
2.3 Insulin API Sales by Region (2017-2028)
2.3.1 Global Insulin API Sales by Region: 2017-2022
2.3.2 Global Insulin API Sales Forecast by Region (2023-2028)
2.3.3 Global Insulin API Sales Market Share by Region (2017-2028)
2.4 Insulin API Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Insulin API Revenue by Region: 2017-2022
2.4.2 Global Insulin API Revenue Forecast by Region (2023-2028)
2.4.3 Global Insulin API Revenue Market Share by Region (2017-2028)
3 Global Insulin API by Manufacturers
3.1 Global Top Insulin API Manufacturers by Sales
3.1.1 Global Insulin API Sales by Manufacturer (2017-2022)
3.1.2 Global Insulin API Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Insulin API Manufacturers by Revenue
3.2.1 Global Insulin API Revenue by Manufacturer (2017-2022)
3.2.2 Global Insulin API Revenue Share by Manufacturer (2017-2022)
3.3 Global Insulin API Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Insulin API Manufacturers Covered: Ranking by Revenue
3.4.2 Global Insulin API Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Insulin API Manufacturing Base Distribution, Product Type
3.5.1 Insulin API Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Insulin API Product Type
3.5.3 Date of International Manufacturers Enter into Insulin API Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novo Nordisk
4.1.1 Novo Nordisk Corporation Information
4.1.2 Novo Nordisk Description, Business Overview
4.1.3 Novo Nordisk Insulin API Products Offered
4.1.4 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Novo Nordisk Insulin API Sales by Product in 2021
4.1.6 Novo Nordisk Insulin API Sales by Application in 2021
4.1.7 Novo Nordisk Insulin API Sales by Geographic Area in 2021
4.1.8 Novo Nordisk Recent Developments
4.2 Sanofi-Aventis
4.2.1 Sanofi-Aventis Corporation Information
4.2.2 Sanofi-Aventis Description, Business Overview
4.2.3 Sanofi-Aventis Insulin API Products Offered
4.2.4 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Sanofi-Aventis Insulin API Sales by Product in 2021
4.2.6 Sanofi-Aventis Insulin API Sales by Application in 2021
4.2.7 Sanofi-Aventis Insulin API Sales by Geographic Area in 2021
4.2.8 Sanofi-Aventis Recent Developments
4.3 Eli Lilly
4.3.1 Eli Lilly Corporation Information
4.3.2 Eli Lilly Description, Business Overview
4.3.3 Eli Lilly Insulin API Products Offered
4.3.4 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Eli Lilly Insulin API Sales by Product in 2021
4.3.6 Eli Lilly Insulin API Sales by Application in 2021
4.3.7 Eli Lilly Insulin API Sales by Geographic Area in 2021
4.3.8 Eli Lilly Recent Developments
4.4 Tonghua Dongbao
4.4.1 Tonghua Dongbao Corporation Information
4.4.2 Tonghua Dongbao Description, Business Overview
4.4.3 Tonghua Dongbao Insulin API Products Offered
4.4.4 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Tonghua Dongbao Insulin API Sales by Product in 2021
4.4.6 Tonghua Dongbao Insulin API Sales by Application in 2021
4.4.7 Tonghua Dongbao Insulin API Sales by Geographic Area in 2021
4.4.8 Tonghua Dongbao Recent Developments
4.5 Ganlee
4.5.1 Ganlee Corporation Information
4.5.2 Ganlee Description, Business Overview
4.5.3 Ganlee Insulin API Products Offered
4.5.4 Ganlee Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Ganlee Insulin API Sales by Product in 2021
4.5.6 Ganlee Insulin API Sales by Application in 2021
4.5.7 Ganlee Insulin API Sales by Geographic Area in 2021
4.5.8 Ganlee Recent Developments
4.6 United Laboratory
4.6.1 United Laboratory Corporation Information
4.6.2 United Laboratory Description, Business Overview
4.6.3 United Laboratory Insulin API Products Offered
4.6.4 United Laboratory Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.6.5 United Laboratory Insulin API Sales by Product in 2021
4.6.6 United Laboratory Insulin API Sales by Application in 2021
4.6.7 United Laboratory Insulin API Sales by Geographic Area in 2021
4.6.8 United Laboratory Recent Development
4.7 Biocon
4.7.1 Biocon Corporation Information
4.7.2 Biocon Description, Business Overview
4.7.3 Biocon Insulin API Products Offered
4.7.4 Biocon Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Biocon Insulin API Sales by Product in 2021
4.7.6 Biocon Insulin API Sales by Application in 2021
4.7.7 Biocon Insulin API Sales by Geographic Area in 2021
4.7.8 Biocon Recent Development
4.8 Amphastar
4.8.1 Amphastar Corporation Information
4.8.2 Amphastar Description, Business Overview
4.8.3 Amphastar Insulin API Products Offered
4.8.4 Amphastar Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Amphastar Insulin API Sales by Product in 2021
4.8.6 Amphastar Insulin API Sales by Application in 2021
4.8.7 Amphastar Insulin API Sales by Geographic Area in 2021
4.8.8 Amphastar Recent Development
4.9 Wockhardt
4.9.1 Wockhardt Corporation Information
4.9.2 Wockhardt Description, Business Overview
4.9.3 Wockhardt Insulin API Products Offered
4.9.4 Wockhardt Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Wockhardt Insulin API Sales by Product in 2021
4.9.6 Wockhardt Insulin API Sales by Application in 2021
4.9.7 Wockhardt Insulin API Sales by Geographic Area in 2021
4.9.8 Wockhardt Recent Development
4.10 Julphar Diabetes
4.10.1 Julphar Diabetes Corporation Information
4.10.2 Julphar Diabetes Description, Business Overview
4.10.3 Julphar Diabetes Insulin API Products Offered
4.10.4 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Julphar Diabetes Insulin API Sales by Product in 2021
4.10.6 Julphar Diabetes Insulin API Sales by Application in 2021
4.10.7 Julphar Diabetes Insulin API Sales by Geographic Area in 2021
4.10.8 Julphar Diabetes Recent Development
4.11 Torrent Pharma
4.11.1 Torrent Pharma Corporation Information
4.11.2 Torrent Pharma Description, Business Overview
4.11.3 Torrent Pharma Insulin API Products Offered
4.11.4 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Torrent Pharma Insulin API Sales by Product in 2021
4.11.6 Torrent Pharma Insulin API Sales by Application in 2021
4.11.7 Torrent Pharma Insulin API Sales by Geographic Area in 2021
4.11.8 Torrent Pharma Recent Development
5 Breakdown Data by Type
5.1 Global Insulin API Sales by Type (2017-2028)
5.1.1 Global Insulin API Sales by Type (2017-2022)
5.1.2 Global Insulin API Sales Forecast by Type (2023-2028)
5.1.3 Global Insulin API Sales Market Share by Type (2017-2028)
5.2 Global Insulin API Revenue Forecast by Type (2017-2028)
5.2.1 Global Insulin API Revenue by Type (2017-2022)
5.2.2 Global Insulin API Revenue Forecast by Type (2023-2028)
5.2.3 Global Insulin API Revenue Market Share by Type (2017-2028)
5.3 Insulin API Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Insulin API Sales by Application (2017-2028)
6.1.1 Global Insulin API Sales by Application (2017-2022)
6.1.2 Global Insulin API Sales Forecast by Application (2023-2028)
6.1.3 Global Insulin API Sales Market Share by Application (2017-2028)
6.2 Global Insulin API Revenue Forecast by Application (2017-2028)
6.2.1 Global Insulin API Revenue by Application (2017-2022)
6.2.2 Global Insulin API Revenue Forecast by Application (2023-2028)
6.2.3 Global Insulin API Revenue Market Share by Application (2017-2028)
6.3 Insulin API Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Insulin API Market Size YoY Growth 2017-2028
7.2 North America Insulin API Market Facts & Figures by Country
7.2.1 North America Insulin API Sales by Country (2017-2028)
7.2.2 North America Insulin API Revenue by Country (2017-2028)
7.3 North America Insulin API Sales by Type
7.4 North America Insulin API Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Insulin API Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Insulin API Market Facts & Figures by Region
8.2.1 Asia-Pacific Insulin API Sales by Region (2017-2028)
8.2.2 Asia-Pacific Insulin API Revenue by Region (2017-2028)
8.3 Asia-Pacific Insulin API Sales by Type
8.4 Asia-Pacific Insulin API Sales by Application
9 Europe
9.1 Europe Insulin API Market Size YoY Growth 2017-2028
9.2 Europe Insulin API Market Facts & Figures by Country
9.2.1 Europe Insulin API Sales by Country (2017-2028)
9.2.2 Europe Insulin API Revenue by Country (2017-2028)
9.3 Europe Insulin API Sales by Type
9.4 Europe Insulin API Sales by Application
10 Latin America
10.1 Latin America Insulin API Market Size YoY Growth 2017-2028
10.2 Latin America Insulin API Market Facts & Figures by Country
10.2.1 Latin America Insulin API Sales by Country (2017-2028)
10.2.2 Latin America Insulin API Revenue by Country (2017-2028)
10.3 Latin America Insulin API Sales by Type
10.4 Latin America Insulin API Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Insulin API Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Insulin API Market Facts & Figures by Country
11.2.1 Middle East and Africa Insulin API Sales by Country (2017-2028)
11.2.2 Middle East and Africa Insulin API Revenue by Country (2017-2028)
11.3 Middle East and Africa Insulin API Sales by Type
11.4 Middle East and Africa Insulin API Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Insulin API Supply Chain Analysis
12.2 Insulin API Key Raw Materials and Upstream Suppliers
12.3 Insulin API Clients Analysis
12.4 Insulin API Sales Channel and Sales Model Analysis
12.4.1 Insulin API Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Insulin API Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Insulin API Distributors
13 Market Dynamics
13.1 Insulin API Industry Trends
13.2 Insulin API Market Drivers
13.3 Insulin API Market Challenges
13.4 Insulin API Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Insulin API Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Regular Human Insulin
Table 3. Major Manufacturers of Insulin Analogue
Table 4. Global Insulin API Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Insulin API Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Insulin API Sales by Region (2017-2022) & (K Units)
Table 7. Global Insulin API Sales Forecast by Region (2023-2028) & (K Units)
Table 8. Global Insulin API Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Insulin API Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Insulin API Sales by Manufacturer (2017-2022) & (K Units)
Table 11. Global Insulin API Sales Share by Manufacturer (2017-2022)
Table 12. Insulin API Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Insulin API Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Insulin API Price (2017-2022) & (USD/Unit)
Table 15. Ranking of Global Top Insulin API Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Insulin API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Insulin API by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin API as of 2021)
Table 18. Insulin API Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Insulin API Product Type
Table 20. Date of International Manufacturers Enter into Insulin API Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Novo Nordisk Corporation Information
Table 23. Novo Nordisk Description and Business Overview
Table 24. Novo Nordisk Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 25. Novo Nordisk Insulin API Product
Table 26. Novo Nordisk Insulin API Sales Proportion of Insulin API by Product in 2021
Table 27. Novo Nordisk Insulin API Sales Proportion of Insulin API by Application in 2021
Table 28. Novo Nordisk Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 29. Novo Nordisk Recent Development
Table 30. Sanofi-Aventis Corporation Information
Table 31. Sanofi-Aventis Description and Business Overview
Table 32. Sanofi-Aventis Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 33. Sanofi-Aventis Insulin API Product
Table 34. Sanofi-Aventis Insulin API Sales Proportion of Insulin API by Product in 2021
Table 35. Sanofi-Aventis Insulin API Sales Proportion of Insulin API by Application in 2021
Table 36. Sanofi-Aventis Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 37. Sanofi-Aventis Recent Development
Table 38. Eli Lilly Corporation Information
Table 39. Eli Lilly Description and Business Overview
Table 40. Eli Lilly Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 41. Eli Lilly Insulin API Product
Table 42. Eli Lilly Insulin API Sales Proportion of Insulin API by Product in 2021
Table 43. Eli Lilly Insulin API Sales Proportion of Insulin API by Application in 2021
Table 44. Eli Lilly Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 45. Eli Lilly Recent Development
Table 46. Tonghua Dongbao Corporation Information
Table 47. Tonghua Dongbao Description and Business Overview
Table 48. Tonghua Dongbao Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 49. Tonghua Dongbao Insulin API Product
Table 50. Tonghua Dongbao Insulin API Sales Proportion of Insulin API by Product in 2021
Table 51. Tonghua Dongbao Insulin API Sales Proportion of Insulin API by Application in 2021
Table 52. Tonghua Dongbao Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 53. Tonghua Dongbao Recent Development
Table 54. Ganlee Corporation Information
Table 55. Ganlee Description and Business Overview
Table 56. Ganlee Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Ganlee Insulin API Product
Table 58. Ganlee Insulin API Sales Proportion of Insulin API by Product in 2021
Table 59. Ganlee Insulin API Sales Proportion of Insulin API by Application in 2021
Table 60. Ganlee Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 61. Ganlee Recent Development
Table 62. United Laboratory Corporation Information
Table 63. United Laboratory Description and Business Overview
Table 64. United Laboratory Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. United Laboratory Insulin API Product
Table 66. United Laboratory Insulin API Sales Proportion of Insulin API by Product in 2021
Table 67. United Laboratory Insulin API Sales Proportion of Insulin API by Application in 2021
Table 68. United Laboratory Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 69. Biocon Corporation Information
Table 70. Biocon Description and Business Overview
Table 71. Biocon Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Biocon Insulin API Product
Table 73. Biocon Insulin API Sales Proportion of Insulin API by Product in 2021
Table 74. Biocon Insulin API Sales Proportion of Insulin API by Application in 2021
Table 75. Biocon Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 76. Amphastar Corporation Information
Table 77. Amphastar Description and Business Overview
Table 78. Amphastar Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 79. Amphastar Insulin API Product
Table 80. Amphastar Insulin API Sales Proportion of Insulin API by Product in 2021
Table 81. Amphastar Insulin API Sales Proportion of Insulin API by Application in 2021
Table 82. Amphastar Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 83. Wockhardt Corporation Information
Table 84. Wockhardt Description and Business Overview
Table 85. Wockhardt Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 86. Wockhardt Insulin API Product
Table 87. Wockhardt Insulin API Sales Proportion of Insulin API by Product in 2021
Table 88. Wockhardt Insulin API Sales Proportion of Insulin API by Application in 2021
Table 89. Wockhardt Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 90. Julphar Diabetes Corporation Information
Table 91. Julphar Diabetes Description and Business Overview
Table 92. Julphar Diabetes Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 93. Julphar Diabetes Insulin API Product
Table 94. Julphar Diabetes Insulin API Sales Proportion of Insulin API by Product in 2021
Table 95. Julphar Diabetes Insulin API Sales Proportion of Insulin API by Application in 2021
Table 96. Julphar Diabetes Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 97. Torrent Pharma Corporation Information
Table 98. Torrent Pharma Description and Business Overview
Table 99. Torrent Pharma Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Torrent Pharma Insulin API Product
Table 101. Torrent Pharma Insulin API Sales Proportion of Insulin API by Product in 2021
Table 102. Torrent Pharma Insulin API Sales Proportion of Insulin API by Application in 2021
Table 103. Torrent Pharma Insulin API Sales Proportion of Insulin API by Geographic Area in 2021
Table 104. Global Insulin API Sales by Type (2017-2022) & (K Units)
Table 105. Global Insulin API Sales Forecast by Type (2023-2028) & (K Units)
Table 106. Global Insulin API Revenue by Type (2017-2022) & (US$ Million)
Table 107. Global Insulin API Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 108. Global Insulin API Sales by Application (2017-2022) & (K Units)
Table 109. Global Insulin API Sales Forecast by Application (2023-2028) & (K Units)
Table 110. Global Insulin API Revenue by Application (2017-2022) & (US$ Million)
Table 111. Global Insulin API Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 112. North America Insulin API Sales by Country (2017-2022) & (K Units)
Table 113. North America Insulin API Sales by Country (2023-2028) & (K Units)
Table 114. North America Insulin API Revenue by Country (2017-2022) & (US$ Million)
Table 115. North America Insulin API Revenue by Country (2023-2028) & (US$ Million)
Table 116. North America Insulin API Sales by Type (2017-2022) & (K Units)
Table 117. North America Insulin API Sales by Application (2017-2022) & (K Units)
Table 118. Asia-Pacific Insulin API Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Insulin API Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Insulin API Revenue by Region (2017-2028) & (US$ Million)
Table 121. Asia-Pacific Insulin API Revenue by Region (2023-2028) & (US$ Million)
Table 122. Asia-Pacific Insulin API Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Insulin API Sales by Application (2017-2022) & (K Units)
Table 124. Europe Insulin API Sales by Country (2017-2022) & (K Units)
Table 125. Europe Insulin API Sales by Country (2023-2028) & (K Units)
Table 126. Europe Insulin API Revenue by Country (2017-2022) & (US$ Million)
Table 127. Europe Insulin API Revenue by Country (2023-2028) & (US$ Million)
Table 128. Europe Insulin API Sales by Type (2017-2022) & (K Units)
Table 129. Europe Insulin API Sales by Application (2017-2022) & (K Units)
Table 130. Latin America Insulin API Sales by Country (2017-2022) & (K Units)
Table 131. Latin America Insulin API Sales by Country (2023-2028) & (K Units)
Table 132. Latin America Insulin API Revenue by Country (2017-2022) & (US$ Million)
Table 133. Latin America Insulin API Revenue by Country (2023-2028) & (US$ Million)
Table 134. Latin America Insulin API Sales by Type (2017-2022) & (K Units)
Table 135. Latin America Insulin API Sales by Application (2017-2022) & (K Units)
Table 136. Middle East and Africa Insulin API Sales by Country (2017-2022) & (K Units)
Table 137. Middle East and Africa Insulin API Sales by Country (2023-2028) & (K Units)
Table 138. Middle East and Africa Insulin API Revenue by Country (2017-2022) & (US$ Million)
Table 139. Middle East and Africa Insulin API Revenue by Country (2023-2028) & (US$ Million)
Table 140. Middle East and Africa Insulin API Sales by Type (2017-2022) & (K Units)
Table 141. Middle East and Africa Insulin API Sales by Application (2017-2022) & (K Units)
Table 142. Insulin API Key Raw Materials, Industry Status and Trend
Table 143. Insulin API Key Raw Materials and Upstream Suppliers
Table 144. Insulin API Clients Status and Trend
Table 145. Insulin API Typical Clients
Table 146. Insulin API Distributors
Table 147. Insulin API Market Trends
Table 148. Insulin API Market Drivers
Table 149. Insulin API Market Challenges
Table 150. Insulin API Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin API Product Picture
Figure 2. Global Insulin API Sales Market Share by Type in 2021 & 2028
Figure 3. Regular Human Insulin Product Picture
Figure 4. Insulin Analogue Product Picture
Figure 5. Global Insulin API Sales Market Share by Application in 2021 & 2028
Figure 6. Fast-Acting Examples
Figure 7. Premix Examples
Figure 8. Long-Acting Examples
Figure 9. Insulin API Report Years Considered
Figure 10. Global Insulin API Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Insulin API Market Size 2017-2028 (US$ Million)
Figure 12. Global Insulin API Sales 2017-2028 (K Units)
Figure 13. Global Insulin API Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Insulin API Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Insulin API Revenue Market Share by Region (2017-2028)
Figure 16. Global Insulin API Sales Share by Manufacturer in 2021
Figure 17. Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Insulin API Sales Market Share Forecast by Type (2017-2028)
Figure 19. Global Insulin API Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Insulin API Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 21. Global Insulin API Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Insulin API Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Insulin API Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 24. North America Insulin API Revenue 2017-2028 (US$ Million)
Figure 25. North America Insulin API Sales Market Share by Type (2017-2022)
Figure 26. North America Insulin API Sales Market Share by Application (2017-2022)
Figure 27. Asia-Pacific Insulin API Revenue 2017-2028 (US$ Million)
Figure 28. Asia-Pacific Insulin API Sales Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Insulin API Revenue Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Insulin API Sales Market Share by Type (2017-2022)
Figure 31. Asia-Pacific Insulin API Sales Market Share by Application (2017-2022)
Figure 32. Europe Insulin API Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Europe Insulin API Sales Market Share by Country (2017-2028)
Figure 34. Europe Insulin API Revenue Market Share by Country (2017-2028)
Figure 35. Europe Insulin API Sales Market Share by Type (2017-2022)
Figure 36. Europe Insulin API Sales Market Share by Application (2017-2022)
Figure 37. Latin America Insulin API Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Latin America Insulin API Sales Market Share by Country (2017-2028)
Figure 39. Latin America Insulin API Revenue Market Share by Country (2017-2022)
Figure 40. Latin America Insulin API Sales Market Share by Type (2017-2022)
Figure 41. Latin America Insulin API Sales Market Share by Application (2017-2022)
Figure 42. Middle East and Africa Insulin API Revenue Growth Rate 2017-2028 (US$ Million)
Figure 43. Middle East and Africa Insulin API Sales Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Insulin API Revenue Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Insulin API Sales Market Share by Type (2017-2022)
Figure 46. Middle East and Africa Insulin API Sales Market Share by Application (2017-2022)
Figure 47. Insulin API Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Insulin API Raw Materials by Region in 2021
Figure 49. Insulin API Distribution Channels
Figure 50. Global Insulin API Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 51. Global Insulin API Percentage 2017-2028: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs